Cold Multi-Symptom

Description

Cold Multi-symptom is a pharmaceutical formulation designed to address multiple symptoms associated with cold conditions. The product is presented in a dosage form suitable for oral administration. It is formulated to provide relief from various cold symptoms, ensuring a comprehensive approach to symptom management. The specific composition and active ingredients are tailored to enhance efficacy while maintaining safety for the intended patient population.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including minor aches and pains, headache, sore throat, nasal congestion, cough, sneezing, runny nose, and sinus congestion and pressure. Additionally, it aids in clearing nasal passages and provides cough relief to facilitate sleep. The drug also temporarily reduces fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are advised to take 2 caplets every 4 hours as needed. The caplets should be swallowed whole and must not be crushed, chewed, or dissolved to ensure proper release and absorption of the medication. It is important to note that the total dosage should not exceed 10 caplets within a 24-hour period.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate dosing guidance.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If uncertain about the presence of acetaminophen in other medications, consult a healthcare professional.

• Concurrent use with prescription monoamine oxidase inhibitors (MAOIs) or within 2 weeks of discontinuing an MAOI, as this may lead to serious drug interactions. If there is uncertainty regarding the presence of an MAOI in a prescription medication, seek guidance from a healthcare professional.

• History of allergic reactions to this product or any of its ingredients, as this may result in severe allergic responses.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of liver damage if the maximum daily dose of 10 caplets (3,250 mg acetaminophen) is exceeded. It is critical to note that severe liver damage may occur if more than 4,000 mg of acetaminophen is taken within 24 hours, particularly when combined with other medications containing acetaminophen, the consumption of three or more alcoholic drinks daily, or the use of other acetaminophen-containing products.

Acetaminophen may also lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

Healthcare professionals should advise patients to consult a doctor before using this product if they have any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, difficulty urinating due to an enlarged prostate gland, persistent or chronic cough (especially associated with smoking), asthma, emphysema, or a cough that produces excessive phlegm. Additionally, patients should be cautioned to seek advice from a doctor or pharmacist if they are concurrently taking the anticoagulant warfarin or any sedatives or tranquilizers.

In cases of accidental overdose, immediate medical attention is essential. Patients should contact a doctor or the Poison Control Center at 1-800-222-1222 without delay, as prompt intervention is crucial for both adults and children, even in the absence of noticeable symptoms.

Patients should discontinue use and consult a healthcare provider if they experience nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond 7 days; if fever worsens or lasts more than 3 days; if redness or swelling occurs; if new symptoms develop; or if a cough recurs or is accompanied by a rash or headache lasting longer than usual. These symptoms may indicate a serious underlying condition that requires further evaluation.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly related to liver health and allergic responses. The product contains acetaminophen, and exceeding the maximum daily dose of 10 caplets (3,250 mg acetaminophen) within 24 hours may lead to severe liver damage. This risk is heightened if patients take more than 4,000 mg of acetaminophen in 24 hours, consume three or more alcoholic drinks daily while using the product, or use other medications containing acetaminophen concurrently.

In addition to liver-related concerns, there is an allergy alert associated with acetaminophen, which may cause severe skin reactions. Symptoms of such reactions can include skin reddening, blisters, and rash. If any of these symptoms occur, patients are advised to discontinue use and seek medical assistance immediately.

Common adverse reactions reported during the use of this product include excitability, particularly in children, and marked drowsiness. The use of alcohol, sedatives, or tranquilizers may exacerbate drowsiness, and patients are advised to avoid alcoholic beverages and exercise caution when driving or operating machinery.

Patients should discontinue use and consult a healthcare professional if they experience nervousness, dizziness, or sleeplessness. Additionally, worsening pain, nasal congestion, or cough lasting more than seven days, fever lasting more than three days, redness or swelling, new symptoms, or a cough that returns or occurs with a rash or headache that persists should prompt medical consultation.

Before using this product, patients with pre-existing conditions such as liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or urinary difficulties due to an enlarged prostate gland should seek medical advice. Furthermore, individuals with a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or those experiencing a cough with excessive phlegm should also consult a healthcare provider. Patients taking the blood-thinning medication warfarin or those on sedatives or tranquilizers should discuss their use of this product with a doctor or pharmacist prior to administration.

Drug Interactions

Concurrent use of this medication with any other drug containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose and potential hepatotoxicity.

The use of this medication is also contraindicated in patients currently taking a prescription monoamine oxidase inhibitor (MAOI) for conditions such as depression, psychiatric or emotional disorders, or Parkinson’s disease. Additionally, it should not be used for at least two weeks following the discontinuation of an MAOI.

Caution is advised when this medication is used in conjunction with warfarin, a blood-thinning agent. Patients should consult with a healthcare professional prior to use to assess the need for monitoring or dosage adjustments.

Furthermore, the concomitant use of this medication with sedatives or tranquilizers should be approached with caution. Patients are advised to seek guidance from a healthcare provider before combining these agents, as the combination may enhance drowsiness. Alcohol, sedatives, and tranquilizers can further exacerbate this effect, leading to increased sedation and potential impairment.

Packaging & NDC

Below are the non-prescription pack sizes of Cold Multi-Symptom (acetaminophen, chlorpheniramine maleate, dextromethorphan hbr and phenylephrine hci). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. There is a potential for excitability to occur, particularly in children. For patients aged 12 years and older, the recommended dosage is 2 caplets every 4 hours, with a maximum of 10 caplets in a 24-hour period.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should be aware of the potential risks associated with the use of this product, which contains acetaminophen. The maximum daily dose is limited to 10 caplets (3,250 mg of acetaminophen) within a 24-hour period. It is critical to note that severe liver damage may occur if the total acetaminophen intake exceeds 4,000 mg in 24 hours, particularly when combined with other medications containing acetaminophen.

Additionally, patients who consume three or more alcoholic drinks daily are at an increased risk of severe liver damage when using this product. Therefore, it is strongly advised that patients with liver disease consult a healthcare professional prior to use to assess the appropriateness of this medication and to discuss any necessary dosage adjustments or monitoring requirements.

Overdosage

In the event of overdosage, it is critical to recognize the potential risks associated with excessive intake of this product, particularly due to its acetaminophen content.

Maximum Daily Dose The maximum recommended daily dose of this product is 10 caplets, which equates to 3,250 mg of acetaminophen within a 24-hour period. Exceeding this dosage significantly increases the risk of adverse effects.

Risk of Severe Liver Damage Severe liver damage may occur under several circumstances:

• Ingestion of more than 4,000 mg of acetaminophen within 24 hours, especially when combined with other medications that also contain acetaminophen.

• Daily consumption of three or more alcoholic beverages while using this product.

• Concurrent use of this product with other acetaminophen-containing medications.

Recommended Actions Healthcare professionals should advise patients to adhere strictly to the recommended dosage guidelines. In cases of suspected overdosage, immediate medical attention is warranted. Monitoring liver function and providing supportive care are essential components of management. It is advisable to consider the use of N-acetylcysteine as an antidote in cases of significant acetaminophen overdose, following established protocols for treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions: severe skin reactions, which may manifest as skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use and seek medical assistance promptly.

Patient Counseling

Healthcare providers should advise patients to contact a doctor or the Poison Control Center (1-800-222-1222) immediately in the event of an accidental overdose. It is crucial to emphasize that taking more than the recommended dose may lead to liver damage, and prompt medical attention is essential for both adults and children, even if no signs or symptoms are present.

Patients should be instructed not to exceed the recommended dosage to minimize the risk of adverse effects. It is important to inform patients that excitability may occur, particularly in children, and that marked drowsiness is a possible side effect.

Healthcare providers should caution patients that the use of alcohol, sedatives, and tranquilizers may enhance drowsiness. Therefore, patients are advised to avoid alcoholic beverages while taking this medication. Additionally, patients should be made aware of the need for caution when driving a motor vehicle or operating machinery due to the potential for drowsiness.

Storage and Handling

The product is supplied in a blister pack configuration. It is essential to store the product at room temperature, specifically within the range of 20° to 25°C (68° to 77°F). Healthcare professionals should ensure that the blister pack remains intact; the product should not be used if the blister is torn or open, as this may compromise the integrity of the medication.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cold Multi-Symptom, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)